{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:31:36Z","timestamp":1790793096004,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"23","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,19]],"date-time":"2021-04-19T00:00:00Z","timestamp":1618790400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.vaccine.2021.04.030","type":"journal-article","created":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T04:11:49Z","timestamp":1619842309000},"page":"3169-3178","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Persistence of neutralizing antibody and its protective efficacy induced by a live attenuated tetravalent dengue vaccine, KD-382, in cynomolgus monkeys"],"prefix":"10.1016","volume":"39","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4593-4902","authenticated-orcid":false,"given":"Masaya","family":"Yoshimura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiko","family":"Shinmura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Shishido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-509X","authenticated-orcid":false,"given":"Shota","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Kameyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kengo","family":"Sonoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sutee","family":"Yoksan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Kimachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7446","key":"10.1016\/j.vaccine.2021.04.030_b0005","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.vaccine.2021.04.030_b0010","doi-asserted-by":"crossref","unstructured":"Halstead SB. Dengue. Lancet 2007;c370(9599):1644\u201352. https:\/\/doi.org\/10.1038\/nature12060.","DOI":"10.1016\/S0140-6736(07)61687-0"},{"key":"10.1016\/j.vaccine.2021.04.030_b0015","doi-asserted-by":"crossref","unstructured":"Nimmannitya S, Halstead SB, Cohen SN, Margiotta MR. Dengue and chikungunya virus infection in man in Thailand, 1962-1964. I. Observations on hospitalized patients with hemorrhagic fever. Am J Trop Med Hyg 1969;18(6):954\u201371. https:\/\/doi.org\/10.4269\/ajtmh.1969.18.954.","DOI":"10.4269\/ajtmh.1969.18.954"},{"issue":"5596","key":"10.1016\/j.vaccine.2021.04.030_b0020","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/265739a0","article-title":"Antibody-enhanced dengue virus infection in primate leukocytes","volume":"265","author":"Halstead","year":"1977","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.vaccine.2021.04.030_b0025","doi-asserted-by":"crossref","first-page":"3928","DOI":"10.1128\/jvi.62.11.3928-3933.1988","article-title":"Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells","volume":"62","author":"Kontny","year":"1988","journal-title":"J Virol"},{"key":"10.1016\/j.vaccine.2021.04.030_b0030","unstructured":"World Health Organization. Dengue vaccine: WHO position paper. July 2016;91(30):349\u2013364."},{"key":"10.1016\/j.vaccine.2021.04.030_b0035","unstructured":"World Health Organization. Background Paper on Dengue Vaccines. April 2018;10(2):1\u201362."},{"issue":"13","key":"10.1016\/j.vaccine.2021.04.030_b0040","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1056\/NEJMoa1506223","article-title":"Efficacy and long-term safety of a dengue vaccine in regions of endemic disease","volume":"373","author":"Hadinegoro","year":"2015","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.vaccine.2021.04.030_b0045","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1080\/21645515.2019.1578595","article-title":"Long-term immunogenicity and safety of tetravalent dengue vaccine (CYD-TDV) in healthy populations in Singapore and Vietnam: 4-year follow-up of randomized, controlled, phase II trials","volume":"15","author":"Tran","year":"2019","journal-title":"Hum Vaccin Immunother"},{"issue":"5","key":"10.1016\/j.vaccine.2021.04.030_b0050","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1093\/infdis\/jix609","article-title":"Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America","volume":"217","author":"Moodie","year":"2018","journal-title":"J Infect Dis"},{"issue":"4","key":"10.1016\/j.vaccine.2021.04.030_b0055","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1800820","article-title":"Effect of dengue serostatus on dengue vaccine safety and efficacy","volume":"379","author":"Sridhar","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.04.030_b0060","doi-asserted-by":"crossref","unstructured":"Dengue vaccine: WHO position paper, September 2018 - Recommendations. Vaccine 2019;37(35):4848\u20139. https:\/\/doi.org\/10.1016\/j.vaccine.2018.09.063.","DOI":"10.1016\/j.vaccine.2018.09.063"},{"issue":"42","key":"10.1016\/j.vaccine.2021.04.030_b0065","doi-asserted-by":"crossref","first-page":"7251","DOI":"10.1016\/j.vaccine.2011.07.020","article-title":"Development of DENVax: a chimeric dengue-2 PDK-53-based tetravalent vaccine for protection against dengue fever","volume":"29","author":"Osorio","year":"2011","journal-title":"Vaccine"},{"issue":"21","key":"10.1016\/j.vaccine.2021.04.030_b0070","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1056\/NEJMoa1903869","article-title":"Efficacy of a tetravalent dengue vaccine in healthy children and adolescents","volume":"381","author":"Biswal","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2021.04.030_b0075","doi-asserted-by":"crossref","unstructured":"L\u00f3pez-Medina E, Biswal S, Saez-Llorens X, Borja-Tabora C, Bravo L, Sirivichayakul C, et al. Efficacy of a dengue vaccine candidate (TAK-003) in healthy children and adolescents two years after vaccination. J. Infect. Dis jiaa761, https:\/\/doi.org\/10.1093\/infdis\/jiaa761.","DOI":"10.1093\/infdis\/jiaa761"},{"issue":"7","key":"10.1016\/j.vaccine.2021.04.030_b0080","doi-asserted-by":"crossref","first-page":"e04506","DOI":"10.1016\/j.heliyon.2020.e04506","article-title":"Well-balanced immune response and protective efficacy induced by a single dose of live attenuated tetravalent dengue vaccine (KD-382) in monkeys","volume":"6","author":"Yoshimura","year":"2020","journal-title":"Heliyon"},{"issue":"8","key":"10.1016\/j.vaccine.2021.04.030_b0085","doi-asserted-by":"crossref","first-page":"455","DOI":"10.6061\/clinics\/2016(08)08","article-title":"Age and regional differences in clinical presentation and risk of hospitalization for dengue in Brazil, 2000\u20132014","volume":"71","author":"Burattini","year":"2016","journal-title":"Clinics (Sao Paulo)"},{"issue":"10","key":"10.1016\/j.vaccine.2021.04.030_b0090","doi-asserted-by":"crossref","first-page":"e0007785","DOI":"10.1371\/journal.pntd.0007785","article-title":"Dengue viral infection in Indonesia: epidemiology, diagnostic challenges, and mutations from an observational cohort study","volume":"13","author":"Utama","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"9","key":"10.1016\/j.vaccine.2021.04.030_b0095","doi-asserted-by":"crossref","first-page":"e0006817","DOI":"10.1371\/journal.pntd.0006817","article-title":"Clinical manifestations of dengue in relation to dengue serotype and genotype in Malaysia: a retrospective observational study","volume":"12","author":"Suppiah","year":"2018","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.vaccine.2021.04.030_b0100","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.4269\/ajtmh.15-0337","article-title":"Forty Years of Dengue Surveillance at a Tertiary Pediatric Hospital in Bangkok, Thailand, 1973\u20132012","volume":"94","author":"Nisalak","year":"2016","journal-title":"Am J Trop Med Hyg"},{"issue":"10","key":"10.1016\/j.vaccine.2021.04.030_b0105","doi-asserted-by":"crossref","first-page":"4977","DOI":"10.1128\/JCM.43.10.4977-4983.2005","article-title":"Serotype-specific detection of dengue viruses in a fourplex real-time reverse transcriptase PCR assay","volume":"43","author":"Johnson","year":"2005","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2021.04.030_b0110","unstructured":"Guidelines for Proper Conduct of Animal Experiments. Science Council of Japan; 2006."},{"issue":"1","key":"10.1016\/j.vaccine.2021.04.030_b0115","doi-asserted-by":"crossref","first-page":"30","DOI":"10.4269\/ajtmh.1952.1.30","article-title":"Research on dengue during World War II","volume":"1","author":"Sabin","year":"1952","journal-title":"Am J Trop Med Hyg"},{"issue":"4839","key":"10.1016\/j.vaccine.2021.04.030_b0120","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1126\/science.239.4839.476","article-title":"Pathogenesis of dengue: challenges to molecular biology","volume":"239","author":"Halstead","year":"1988","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.vaccine.2021.04.030_b0125","doi-asserted-by":"crossref","first-page":"910","DOI":"10.4269\/ajtmh.2007.77.910","article-title":"Analysis of repeat hospital admissions for dengue to estimate the frequency of third or fourth dengue infections resulting in admissions and dengue hemorrhagic fever, and serotype sequences","volume":"77","author":"Gibbons","year":"2007","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/j.vaccine.2021.04.030_b0130","doi-asserted-by":"crossref","unstructured":"Kirkpatrick BD, Whitehead SS, Pierce KK, Tibery CM, Grier PL, Hynes NA, et al. The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model. Sci Transl Med 2016;8(330):330ra36. https:\/\/doi.org\/10.1126\/scitranslmed.aaf1517.","DOI":"10.1126\/scitranslmed.aaf1517"},{"key":"10.1016\/j.vaccine.2021.04.030_b0135","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3389\/fimmu.2016.00218","article-title":"The cellular bases of antibody responses during dengue virus infection","volume":"7","author":"Yam-Puc","year":"2016","journal-title":"Front Immunol"},{"issue":"1","key":"10.1016\/j.vaccine.2021.04.030_b0140","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/nrmicro.2015.2","article-title":"Dengue vaccine: hypotheses to understand CYD-TDV-induced protection","volume":"14","author":"Guy","year":"2016","journal-title":"Nat Rev Microbiol"},{"issue":"8","key":"10.1016\/j.vaccine.2021.04.030_b0145","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.4049\/jimmunol.1401597","article-title":"CD8+ T cells prevent antigen-induced antibody-dependent enhancement of dengue disease in mice","volume":"193","author":"Zellweger","year":"2014","journal-title":"J Immunol"},{"issue":"31","key":"10.1016\/j.vaccine.2021.04.030_b0150","doi-asserted-by":"crossref","first-page":"E4256","DOI":"10.1073\/pnas.1505956112","article-title":"Dengue virus infection elicits highly polarized CX3CR1+ cytotoxic CD4+ T cells associated with protective immunity","volume":"112","author":"Weiskopf","year":"2015","journal-title":"Proc Natl Acad Sci U S A"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X21004771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:56:38Z","timestamp":1759402598000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X21004771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":30,"journal-issue":{"issue":"23","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S0264410X21004771"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.030","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Persistence of neutralizing antibody and its protective efficacy induced by a live attenuated tetravalent dengue vaccine, KD-382, in cynomolgus monkeys","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2021.04.030","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}